Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

By Naoi Yasuto  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

By Lamond Nathan   Skedgel Chris   Rayson Daniel   Lethbridge Lynn   Younis Tallal  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1115-1123

Springer Publishing Company

Access to resources Recommend Favorite

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

By Eiermann W.   Rezai M.   Kmmel S.   Khn T.   Warm M.   Friedrichs K.   Schneeweiss A.   Markmann S.   Eggemann H.   Hilfrich J.   Jackisch C.   Witzel I.   Eidtmann H.   Bachinger A.   Hell S.   Blohmer J.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 618-624

Oxford University Press

Access to resources Recommend Favorite

Signals involved in thymocyte positive and negative selection

By Mariathasan S.   Jones R.G.   Ohashi P.S.  

Seminars in Immunology, Vol. 11, Iss. 4, 1999-08 ,pp. : 263-272

Academic Press

Access to resources Recommend Favorite

Prognostic variables in node-negative and node-positive breast cancer - Introduction

By Gasparini G.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 193-194

Springer Publishing Company

Access to resources Recommend Favorite